VSI-360™ for Breast Lumpectomy

About Clarix Imaging

Clarix Imaging is a private, commercial-stage medical device company founded in 2017 and based in San Francisco. It has developed and received FDA clearance for the VSI-360™, a novel imaging system that generates true 3D reconstructions of surgical specimens to help surgeons assess margin status during breast cancer lumpectomy procedures. The technology, born from NIH-funded research at the University of Chicago, aims to reduce the need for repeat surgeries by providing intraoperative clarity. The company is currently in early revenue generation, deploying its system to hospital partners and conducting prospective clinical trials.

Therapeutic Areas